MENU
RNAC
AS OF
Dec 24 closing price
Price
$6.76
Change
+$0.33 (+5.13%)
Capitalization
175.78M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cartesian Therapeutics (RNAC) Ownership - Who owns Cartesian Therapeutics?

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
175.78M
P/E Ratio
1.98
Total Cash
143.38M
Projected Growth
N/A
Total Debt
12.6M
Revenue
1.09M
Risk (Beta)
0.96
Dividend Yield
N/A
Total Cash/Share
5.51
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price

Fundamentals

RNAC
Capitalization
176M
P/E Ratio
1.98
Risk (Beta)
0.96
Dividend Yield
N/A
Total Cash
143M
Total Cash/Share
5.51
Total Debt
12.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
1.09M
ROE
N/A
Book Value
-35.84M
P/B Ratio
588.24
Cash Flow
N/A
Earnings
-1.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
10.67
Current Revenue Per Employee
6848.48
Dividends Per Share - Security
N/A
EBITDA
-121.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-11.59
Shares Held By Institutions
90.3M
Shares Outstanding - Current
26M
Total Liabilities
409M
Total Volume MTD
N/A
Value
-1
Gain YTD
-62.256
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RNAC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for RNAC
A.I. Advisor
published General Information

General Information

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com